Acute mesenteric venous thrombosis

Revisited in a time of diagnostic clarity

R. J. Grieshop, Michael Dalsing, D. F. Cikrit, S. G. Lalka, Alan Sawchuk

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Historically, mesenteric venous thrombosis (MVT) has been found during laparotomy or at autopsy. Improvements in computed tomography (CT) and ultrasound (U/S) may identify patients earlier in their clinical course. How has this altered the treatment strategy of the authors? This 10-year retrospective study of acute MVT consisted of 12 men and three women (average age 43). Presenting signs and symptoms were nonspecific in 10/15 patients resulting in multiple diagnostic tests. All CT scans (10) and angiograms (4) revealed mesenteric clot. U/S exams detected clot in 6/9 patients. The remaining five patients exhibited clinical signs requiring operations rather than diagnostic studies. The only consistent laboratory abnormality was an elevated white blood cell count in 12/15 patients. Management of MVT varied. Five patients, heparinized once the diagnosis was made, did not experience dysfunction from MVT. Ten patients were not initially treated with heparin and were divided into three groups. Three patients received neither heparin nor surgery and have had no sequelae. MVT contributed to the death of two patients. The remaining five patients were diagnosed in the operating room following bowel resection. Two of these patients received postoperative heparin and had a favorable outcome. Two of the three patients not heparinized after surgery suffered additional bowel infarction. MVT can present as nonspecific abdominal pain, but also as peritonitis requiring operation. CT and U/S can identify patients with early MVT. It appears that heparin has both a primary therapeutic role in early disease and a postoperative adjunctive role in advanced disease. With such care, these patients can expect an acceptable prognosis (86% survival).

Original languageEnglish
Pages (from-to)573-578
Number of pages6
JournalAmerican Surgeon
Volume57
Issue number9
StatePublished - 1991

Fingerprint

Heparin
Tomography
Mesenteric Ischemia
Operating Rooms
Peritonitis
Leukocyte Count
Routine Diagnostic Tests
Laparotomy
Infarction
Abdominal Pain
Signs and Symptoms
Autopsy
Angiography
Retrospective Studies
Survival
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Acute mesenteric venous thrombosis : Revisited in a time of diagnostic clarity. / Grieshop, R. J.; Dalsing, Michael; Cikrit, D. F.; Lalka, S. G.; Sawchuk, Alan.

In: American Surgeon, Vol. 57, No. 9, 1991, p. 573-578.

Research output: Contribution to journalArticle

Grieshop, R. J. ; Dalsing, Michael ; Cikrit, D. F. ; Lalka, S. G. ; Sawchuk, Alan. / Acute mesenteric venous thrombosis : Revisited in a time of diagnostic clarity. In: American Surgeon. 1991 ; Vol. 57, No. 9. pp. 573-578.
@article{e376099ae8834c8ea1abc5ad53d1893d,
title = "Acute mesenteric venous thrombosis: Revisited in a time of diagnostic clarity",
abstract = "Historically, mesenteric venous thrombosis (MVT) has been found during laparotomy or at autopsy. Improvements in computed tomography (CT) and ultrasound (U/S) may identify patients earlier in their clinical course. How has this altered the treatment strategy of the authors? This 10-year retrospective study of acute MVT consisted of 12 men and three women (average age 43). Presenting signs and symptoms were nonspecific in 10/15 patients resulting in multiple diagnostic tests. All CT scans (10) and angiograms (4) revealed mesenteric clot. U/S exams detected clot in 6/9 patients. The remaining five patients exhibited clinical signs requiring operations rather than diagnostic studies. The only consistent laboratory abnormality was an elevated white blood cell count in 12/15 patients. Management of MVT varied. Five patients, heparinized once the diagnosis was made, did not experience dysfunction from MVT. Ten patients were not initially treated with heparin and were divided into three groups. Three patients received neither heparin nor surgery and have had no sequelae. MVT contributed to the death of two patients. The remaining five patients were diagnosed in the operating room following bowel resection. Two of these patients received postoperative heparin and had a favorable outcome. Two of the three patients not heparinized after surgery suffered additional bowel infarction. MVT can present as nonspecific abdominal pain, but also as peritonitis requiring operation. CT and U/S can identify patients with early MVT. It appears that heparin has both a primary therapeutic role in early disease and a postoperative adjunctive role in advanced disease. With such care, these patients can expect an acceptable prognosis (86{\%} survival).",
author = "Grieshop, {R. J.} and Michael Dalsing and Cikrit, {D. F.} and Lalka, {S. G.} and Alan Sawchuk",
year = "1991",
language = "English",
volume = "57",
pages = "573--578",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "9",

}

TY - JOUR

T1 - Acute mesenteric venous thrombosis

T2 - Revisited in a time of diagnostic clarity

AU - Grieshop, R. J.

AU - Dalsing, Michael

AU - Cikrit, D. F.

AU - Lalka, S. G.

AU - Sawchuk, Alan

PY - 1991

Y1 - 1991

N2 - Historically, mesenteric venous thrombosis (MVT) has been found during laparotomy or at autopsy. Improvements in computed tomography (CT) and ultrasound (U/S) may identify patients earlier in their clinical course. How has this altered the treatment strategy of the authors? This 10-year retrospective study of acute MVT consisted of 12 men and three women (average age 43). Presenting signs and symptoms were nonspecific in 10/15 patients resulting in multiple diagnostic tests. All CT scans (10) and angiograms (4) revealed mesenteric clot. U/S exams detected clot in 6/9 patients. The remaining five patients exhibited clinical signs requiring operations rather than diagnostic studies. The only consistent laboratory abnormality was an elevated white blood cell count in 12/15 patients. Management of MVT varied. Five patients, heparinized once the diagnosis was made, did not experience dysfunction from MVT. Ten patients were not initially treated with heparin and were divided into three groups. Three patients received neither heparin nor surgery and have had no sequelae. MVT contributed to the death of two patients. The remaining five patients were diagnosed in the operating room following bowel resection. Two of these patients received postoperative heparin and had a favorable outcome. Two of the three patients not heparinized after surgery suffered additional bowel infarction. MVT can present as nonspecific abdominal pain, but also as peritonitis requiring operation. CT and U/S can identify patients with early MVT. It appears that heparin has both a primary therapeutic role in early disease and a postoperative adjunctive role in advanced disease. With such care, these patients can expect an acceptable prognosis (86% survival).

AB - Historically, mesenteric venous thrombosis (MVT) has been found during laparotomy or at autopsy. Improvements in computed tomography (CT) and ultrasound (U/S) may identify patients earlier in their clinical course. How has this altered the treatment strategy of the authors? This 10-year retrospective study of acute MVT consisted of 12 men and three women (average age 43). Presenting signs and symptoms were nonspecific in 10/15 patients resulting in multiple diagnostic tests. All CT scans (10) and angiograms (4) revealed mesenteric clot. U/S exams detected clot in 6/9 patients. The remaining five patients exhibited clinical signs requiring operations rather than diagnostic studies. The only consistent laboratory abnormality was an elevated white blood cell count in 12/15 patients. Management of MVT varied. Five patients, heparinized once the diagnosis was made, did not experience dysfunction from MVT. Ten patients were not initially treated with heparin and were divided into three groups. Three patients received neither heparin nor surgery and have had no sequelae. MVT contributed to the death of two patients. The remaining five patients were diagnosed in the operating room following bowel resection. Two of these patients received postoperative heparin and had a favorable outcome. Two of the three patients not heparinized after surgery suffered additional bowel infarction. MVT can present as nonspecific abdominal pain, but also as peritonitis requiring operation. CT and U/S can identify patients with early MVT. It appears that heparin has both a primary therapeutic role in early disease and a postoperative adjunctive role in advanced disease. With such care, these patients can expect an acceptable prognosis (86% survival).

UR - http://www.scopus.com/inward/record.url?scp=0025886731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025886731&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 573

EP - 578

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 9

ER -